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 Abstract 
Obesity is a national epidemic in the United States, which both directly and indirectly affects the 
social productivity of individuals, the American macro economy and individuals’ personal health 
and well being. Depression often interferes with an individual’s ability to work, sleep, study, eat, 
and enjoy life.  A maternal state of both obesity and depression may cause serious adverse 
medical conditions in the mother’s child.  Taking steps to treat depression and obesity are critical 
in the construct of modern medicine. This project yields results that have the potential to make 
treatment options better tailored, more efficient, effective and economically-sound for the obese, 
pregnant population. This study was conducted using a collaborative approach, combining 
retrospectively collected patient data from Syracuse University and SUNY Upstate Medical 
Center. Our data shows that morbid obesity is positively correlated with higher incidence of 
depression. This suggests that health care practioners should screen morbidly obese perinatal 
women for depression more frequently and assist these women in accessing psychological 
treatment and weight management options.   
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Executive Summary 
 
 The purpose of this study is to screen women in the peripartum stage of pregnancy using 
the Edinburgh Postnatal Depression Scale.  This information will be used in combination with 
retrospectively collected patient data to match de-identified patients’ presence or abstence of 
depression with her body mass index.  The retrospectively collected data will allow us to collect 
the body mass index (BMI).  The goal of this research is to discern whether obesity (a BMI of 
>30) correlates with greater incidence of depression.  
Body mass index can be calculated by dividing (weight in pounds x 703) by (height in 
inches squared) or by dividing (weight in kilograms) by (height in meters squared).  The ratio of 
BMI is a fairly accurate indicator of an individual’s fatty tissue mass and body mass index is 
used to assess obesity. Obesity is defined as a physiological state where an excess of adipose 
tissue results in a body mass index (BMI) of greater than 30.   
The DSM-V defines perinatal or peripartum depression as major depression that occurs 
during pregnancy or in the period immediately subsequent to delivery [Lara et al., 2015]. 
Depression is typically characterized by reduced interest and pleasure in self, others and the 
environment (anhedonia) and a decrease in general appetite and sexual activity [Weinstock et al., 
2001].   Clinicians characterize the peripartum stage as occuring during pregnancy and up to one 
year postpartum [O’Hara et al., 2013]. Identification of perinatal depression is imperative 
because it may have links to post partum depression (PPD), which can in turn impair the affected 
women’s ability to care for herself and her baby [Lara et al., 2015].  Perinatal and post partum 
depression are associated with high usage of emergency rooms, malnutrition and developmental 
delay of the child and lower quality interactions between the mother and her child [Murray and 
Cooper, 1997; Field 2010]. 
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 The significance of this study cannot be understated.  Depression often interferes with an 
individual’s ability to work, sleep, study, eat, and enjoy life.  From a social and economic 
perspective, individuals who are depressed will not function at their optimal level as members in 
the community.  Obesity is a national epidemic in the United States, which both directly and 
indirectly affects the social productivity of individuals, the American macro economy and 
individuals’ personal health and happiness. A depressed state compounded with obesity is not 
optimal from any perspective. Individuals who are obese and depressed are categorized as being 
at a severe risk for multiple diseases including diabetes, sleep apnea and chronic hypertension 
[Linne, 2004; Garbaciak et al., 1985; Cnattingius et al., 2002].  Furthermore, a maternal state of 
both obesity and depression may also lead to proliferation of serious health conditions in the 
mother’s child [Weinstock et al., 2011].  Taking steps to treat depression and obesity are critical 
in the management of patients. This project will make treatment options better tailored, more 
efficient, effective and economically-sound for the obese, pregnant population.         
The clinical relevance of this study is based on the hypothesis that if there is an increased 
incidence of depression in obese obstetric patients, these patients can be monitored and treated 
for depressive symptoms prior to the postpartum period.  This intervention may help to 
accelerate both the mother’s recovery from depression and may aid in fostering the health of the 
newborn.  If our hypothesis that a greater BMI (Body Mass Index) correlates with a higher 
incidence of depression is correct, this can impact obstetrical care and aid in the treatment of 
patients.  If significant findings are found, it would indicate that obese maternal patients should 
receive mental health screenings throughout pregnancy and psychological treatment should be 
made readily available to this population.  Even if our hypothesis is incorrect, we will still have 
discovered an important finding; that a greater BMI does not correlate with depression in 
v 
 
obstetric patients.  This can help improve the efficiency and effectiveness of obstetrical care, by 
avoiding the added expense of mental health screening and treatment for this group of women.  
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Preface  
 
 
I wish to be a Physician Assistant in the near future and as a medical practitioner, I want to be 
able to provide the highest possible quality care to my patients.  Studies like this one provide 
health care providers valuable information about how they can tailor their treatment to specific 
patients. I also wish to contribute to medical research prior to becoming a practitioner.  The 
joined, collaborative research efforts at Syracuse University and SUNY Upstate Medical Center 
have certainly increased the quality of this project and this project is a statement about the 
importance of collaborative medical science research.   
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Chapter 1 
Introduction 
 
 
Syracuse University’s College of Arts and Sciences notes on their website that, 
“Biotechnology is a rapidly growing, interdisciplinary field that seeks to solve today's most 
challenging problems in such areas as human and animal health, agriculture, and the 
environment ” [Syracuse University College of Arts and Sciences, Biotechnology webpage 
2010]. My capstone project seeks to understand one of America’s most pressing health care 
issues using biotechnological tools.  Specifically, this project will determine whether there is an 
increased prevalence of depression in increasingly obese pregnant patients versus normal weight 
pregnant patients.  I will use an interdisciplinary approach and will draw from retrospectively 
collected clinically measured physiological data and from previous data collected by highly 
trained leaders in the fields of depression and obstetrics (The Department of Obstetrics and 
Gynecology at Upstate Medical University: Correlates and Consequences of Prenatal 
Depression-an exploratory study).  I will review primary data about various levels of obesity and 
its correlation to incidence of depression.  Our goal is to draw a conclusion about the effects of 
obesity, an extraordinarily pressing American public health issue, and correlate it to the 
incidence of depression. 
The broad spectrum, interdisciplinary approach that is characteristic of biotechnology, 
will be particularly useful when evaluating the problem of obesity as it relates to pregnant 
women especially in the face of the medical and social consequences that demand varied 
evaluative methods.  Depression often interferes with an individual’s ability to work, sleep, 
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study, eat, and enjoy life.  From a social and economic perspective, individuals who are 
depressed will not function at their optimal level as members in the community.  Obesity is a 
national epidemic in the United States, which both directly and indirectly affects the social 
productivity of individuals, the American macro economy and individuals’ personal health and 
happiness. A depressed state compounded with obesity is not ideal from any perspective. 
Individuals who are obese and depressed are categorized as being at a severe risk for multiple 
diseases including diabetes, sleep apnea and chronic hypertension [Linne, 2004; Garbaciak et al., 
1985; Cnattingius et al., 2002].  Furthermore, a maternal state of both obesity and depression 
may also lead to proliferation of serious health conditions in the mother’s child [Weinstock et al., 
2011].  Taking steps to treat depression and obesity are critical in modern medical care. This 
project will make treatment options better tailored, more efficient, effect and economically-
sound for the obese, pregnant population.         
The clinical relevance of this study is based on the hypothesis that if there is an increased 
incidence of depression in obese obstetric patients, these patients can be monitored and treated 
for depressive symptoms prior to the postpartum period.  This intervention may help to 
accelerate both the mother’s recovery from depression and may aid in fostering the health of the 
newborn.  If our hypothesis that a greater BMI (Body Mass Index) correlates with a higher 
incidence of depression is correct, this can impact obstetrical care and aid in the treatment of 
patients.  If significant correlation is found, it would indicate that obese maternal patients should 
receive mental health screenings throughout pregnancy and psychological treatment should be 
made readily available to this population.  Even if our hypothesis is incorrect, we will still have 
discerned a significant finding that a greater BMI does not correlate with depression in obstetric 
 
3 
 
patients.  This can help improve the efficiency and effectiveness of obstetrical care, by avoiding 
the added expense of mental health screening and treatment for this group of women.  
The New York Statewide Perinatal Data System’s 2013 database, was used to correlate 
BMI with perinatal depression (See Appendix A for the New York State Birth Certificate and 
Statewide Perinatal Data System Work Booklet).  Using the parameters, they found that for 
obese  and normal weight women, 64.0%  and 71.4% are not depressed at all, 23.1%  and 18.4% 
are a little depressed, 7.1%  and 4.7% are moderately depressed, 0.9%  and 0.7% are very 
depressed and 1.3% and 0.6% are very depressed, respectively, and needed  psychological help 
[New York Statewide Perinatal Data System, 2013].  This information was collected from 
18,000 deidentified Central New York expectant mothers in 2013 and clearly shows that 
perinatal obesity has a strong correlation with depression during pregnancy.  The depression 
scale used to screen the mothers and develop these statistics was a validated assessment ( 
PRAMS, the Pregnancy Risk Assessment Monitoring System), developed by the CDC, Center 
for Disease Control.  This statistical analysis powers our study with high clinical relevance.  The 
goal of this study will be to find whether increasing levels of obesity correlate with increasing 
incidence of depression during the perinatal period.    
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Chapter 2 
Literature Search 
 
 
 
Obesity is a condition where the adipose tissue mass of an individual is beyond the 
physical requirement for such tissue [Singh, 2014; Linne 2004]. Obesity is the result of a surplus 
of energy consumed (energy intake) as compared to energy expended [Singh, 2014].   The 
accumulation of triglycerol, rather than accumulation of carbohydrate glycogen or protein in the 
liver or muscle, is the only way the body can become “excessive” [Sikaris, 2004].  As a tissue, 
adipose tissue is an organ system that can vary enormously between individuals and perhaps 
more so than other tissues in the body [Linne, 2004].  The variations in adipose morphology and 
location in the body can have tremendous implications for health and disease.  Adipose tissue 
acts as an endocrine organ in the body, as it can release adipokines that can affect and regulate 
the functioning of other tissues in the body.  These functions are amplified in the case of obesity 
[Kershaw et al, 2004].  It is important to note that women in general, have a greater proportion of 
subcutaneous fat and lower bone and muscle mass compared to men.  Also notable, is that bone 
density, bone mass and muscle mass all decrease with age in both sexes. The World Health 
Organization has redefined body morphologies as a BMI >25 as overweight and >30 as obese 
[World Health Organization, 1997].  
There are a variety of metabolic genes and gene products that are generally agreed upon 
as associated with causation and proliferation of obesity [Snyder et al., 2003].  Leptin is a 
hormone that communicates with the central nervous system and binds in the hypothalamic 
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arcuate nucleus thereby stimulating production of pro-opiomelanocortin (POMC).  Two active 
products of POMC are alpha-melanocyte stimulating hormome (alpha-MSH) and 
adrenocortioctropin (ACTH).  Alpha MSH binds to its respective receptors in the paraventricular 
nucleus to signal satiety and decrease food intake. [Sikaris, 2004].  Mutations with the leptin 
signaling pathway are rare but are thought to be linked to obesity [Proietto et al, 2004].  Beta- 3 
adrenergic receptor (ADRB3) is expressed in adipose tissue and in normal cases, is involved 
with lipid metabolism and thermogenesis.  A mutation of ADRB3 is associated with obesity 
[Widen et al., 1995; Clement et al., 1995; Kurokawa et al., 2001]. Peroxisome proliferator 
activated peptide receptor gamma (PPAR-gamma) is a nuclear receptor that is essential for 
adipogenesis and regular insulin signaling [Sikaris, 2004].  The Pro12A1a mutation can decrease 
the binding affinity of PPAR-gamma.  However, it has been found that Pro12A1a mutations 
seem to have a compounded, more severe effect in individuals already afflicted with a genetic 
proclivity to obesity, and the Pro12A1a mutation has less of an effect on individuals predisposed 
to have a normal body weight [Ek et al., 1999].  Adiponectin is typically associated with 
maintenance of energy homeostasis, macromolecule metabolism and anti-inflammation.  High 
levels of adiponectin are associated with weight loss [Stumvoll et al, 2002].  A deficit of 
adiponectin may be linked to obesity and polymorphisms of adiponectin are associated with 
obesity, increased weight gain and insulin sensitivity [Stumvoll et al., 2002].   
There are many physiological costs to obesity.  In this study, the physiological costs of 
obesity that have the greatest consequences for pregnancy and maternity will be analyzed. 
 Obstructive sleep apnea is characterized by absence of airflow in spite of thoraco-abdominal 
muscular movement [Sikaris, 2004].  Seventy percent of patients with obstructive sleep apnea 
are obese, likely due to fatty deposits in the neck and pharyngeal area [Malhotrra et al., 2002; 
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Fleetham 1992].  This is very problematic, especially in consideration of fetal development since 
there is a lowering in physiological oxygen saturation in maternal blood during resting hours 
[Series et al., 1993].  This may lead to decreased oxygen delivery to the developing fetus.  
Obstructive sleep apnea is also associated with hypertension and coronary artery disease (CAD) 
[Sikaris, 2004].  The increased incidence of hypertension that is linked to obesity, is also 
associated with increased sympathetic nervous activity.  This increased activity in turn can cause 
hyperinsulinaemia, increased intrarenal pressure and increased levels of hepatic free fatty acids, 
angiotensin II, leptin, central chemoreceptor sensitivity.  In addition, it can reduce baroreceptor 
reflex and the ability to respond to changes in pressure in blood vessels [Sikaris, 2004; Grassi et 
al., 1998].  These conditions also have the potential of effecting oxygenation and nutrient 
availability to the growing fetus in a negative manner.  There is also a greatly increased risk of 
insulin resistance when individuals are obese.  Upwards of 90% of diabetic patients are 
overweight or obese [Albu et al., 1998].  This may be due to the fact that preceding the onset of 
diabetes, weight gain and insulin resistance usually occur [Sikaris, 2004].  Increased levels of 
free fatty acids in the circulation of individuals with increased adipose mass can produce insulin 
resistance in the skeletal muscle and liver and can reduce beta cell functioning and resultant 
release of insulin in the pancreas. This reduction in physiological functioning due to excessive 
fatty acids is called lipotoxicity [Schaffer, 2003].  Poor regulation of insulin and glucose may 
also negatively affect the developing fetus.  Also notable, growth hormone (GH) levels and 
vitamin D levels are lower in obese populations.  Lower vitamin D levels results in higher levels 
of parathyroid hormone (PTH) which in turn affects calcium metabolism [Sikaris, 2004].  Sikaris 
suggests that social isolation and indoor dwelling may somehow be connected to these vitamin 
deficiencies.  Additionally, it should not be overlooked that obesity is associated with a 
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significant community stigma.  Public disapproval and rejection can affect education, 
employment, income, marital status and health care [Sikaris, 2004].  These are important clinical 
factors that are believed to be associated with adversely impacting the person’s quality of life 
and increasing the incidence of depression [Sikaris, 2004].   
Obesity is a world-wide epidemic.  In the United States, it has been reported that 
approximately 44% of women aged 18-49 were obese, 40% of married women in the United 
Arab Emirates are obese and in Sweden, the prevalence of overweight BMIs among the female 
population aged 16-44 doubled in recent years. Obesity is a threat to the health of childbearing-
aged women and their offspring [Linne, 2004].  
 During pregnancy it is normal for the female body to create a buffer of approximately 
30,000 kcal to ensure that there is a sufficient energy resource for the last trimester when fetal 
metabolic demands are high, for anticipated extended lactation and to shield the pregnancy from 
the possibility that there will be food scarcity [Linne, 2004].  However, the weight gain 
recommendations from the Insitute of Medicine (IOM) vary depending on pre-pregnancy BMI.  
It is recommended that obese women, or those women with a BMI >29, gain approximately 
6.8kg, which metabolically is significantly less than 30,000 kCal buffer most women gain during 
pregnancy [Linne, 2004]. 
Obesity during pregnancy places a pregnancy into the high risk for complications 
category.  Obese women as compared to normal weight women have a higher rate of 
hypertensive diagnoses, gestational diabetes, delivery complications, caesarean sections, 
prolonged labor and delivering children with poor health [Linne, 2004; Garbaciak et al., 1985; 
Cnattingius et al., 2002].  Obese women of child-bearing age have a decreased choice of 
contraceptive methods and an increased risk of hyperandrogonadism, amenorrhoea, 
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dysovulation, infertility, hyperinsulinaemia, polycystic ovary syndrome, depression, edometrial 
cancer and breast cancer [Linne, 2004].  During a pregnancy, obese women have an increased 
risk of developing gestational diabetes, hypertension, dyslipidaemia, impaired endothelial 
function leading to preclampsia, back pain, preterm delivery, induced labor, prolonged labor, 
vulvar or perineal lacerations, cesarean section and related complications including infection and 
thromboembolism [Linne, 2004].  It is generally accepted that the average weight women has a 
1-3% chance of developing gestational diabetes.  Obese women have an approximately 17% 
chance of developing gestational diabetes [Linne, 2004].  Obese pregnant women have an 
increased risk of babies to develop spina bifida, macrosomia, head trauma, shoulder dystocia, 
brachial plexus injury, fracture of the clavicle, increased perinatal mortality and hemorrhage after 
delivery [Linne, 2004].  For these reasons, it is clear why obesity places women in a “high risk” 
category during pregnancy. 
 Pregnancy is also characterized by increased psychological vulnerability.  This 
vulnerability can be amplified or minimized by certain factors such as age, health, socio-
economic status and obesity [Della Vedova et al, 2011].  A high risk pregnancy is a pregnancy in 
which a medical factor pertaining to either the mother or the fetus, may adversely affect the 
ultimate outcome of the pregnancy [Levy-Shiff et al., 2002].  When a pregnancy is categorized 
as high risk, the psychological stress of the mother regarding the pregnancy is affected in a 
variety of ways [Levy-Shiff et al., 2002].  Maternal reactions may include depression (as 
analyzed by the present study), regressive behavior, injured self-esteem, reduced confidence and 
self-efficacy, anger directed at low-risk pregnancies, and/or self-recrimination [Levy-Shiff et al., 
2002].  Increased doubt and uncertainty compound the physiological threats of the pregnancy.  
Psychological threats can interfere with the normal adjustment to pregnancy and may actually 
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work to emotionally and psychologically separate the mother from her unborn child [Levy-Shiff 
et al., 2002].  For practitioners who care for women with high risk pregnancies, it is useful to 
monitor the stress-related responses of the expectant mothers.  Maternal psychological state has 
the capacity to affect the immediate situation in the pregnancy and the long term outcome of the 
mother’s ability to care for her child.   
Previous psychological research has been performed on high risk pregnancies, including 
those where mothers had pre-gestational diabetes or gestational diabetes.  Cognitive appraisal of 
pregnancy as a challenge and threat, cognitive appraisal of control, ways of coping, social 
support, depression (via the Beck Depression Inventory), state-trait anxiety, well-being and 
distress (via Pines and Aronson 1981 Burnout Questionnaire), and other psychological symptoms 
have been measured [Levy et al., 2002].  These factors are all relevant and will be considered in 
this study.  Specifically the mother’s primary and secondary cognitive appraisals, coping 
strategies and availability of coping resources are extremely important to monitor [Levy-Shiff et 
al., 2002].  Cognitive appraisal is how the mother assesses her social and physical situations and 
her pregnancy.  Pregnancy may be appraised as a threat, a challenge or a miracle.  Coping 
strategies are considered the cognitive and behavioral efforts in managing the stressors related to 
pregnancy. Lastly, coping resources refer to the social support system available to the mother 
during pregnancy [Levy-Shiff et al., 2002].  
Lack of support throughout pregnancy can increase depression and anxiety symptoms.  
Partner and/or spousal support and family support factor significantly in the presence or absence 
of depressive and anxiety-related symptoms.  Familial support has been shown to be protective 
against mood disorders.  Mothers given a high level of social support during stress-inducing 
stages of their pregnancy had lower levels of circulating stress hormones than did mothers 
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without support [Wadhwa et al., 1996].  This association suggests that there is an relationship 
between the hypothalamic-pituitary-adrenal axis activation, hormone and neurotransmitter 
emission and perceived stress.  Sufficient social support also resulted in reduced negative -affect 
emotions and reduced the likelihood of preterm labor and depression [Oakley et al., 1990]. 
 Likewise, this suggests that there is a potential connection between self perceived or assessed 
stress and incidence of preterm birth.  The absence of familial support is a risk factor for mood 
disorders [Alfaraj et al., 2009; Hammarberg et al., 2013; Pajulo et al., 2001; Rubertsson et al., 
2003; Whisman et al., 2011]. It is also important that the patient’s partner other also have a well 
managed psychological state.  If an adverse psychological state is discovered in the significant 
other, it is important to have a clear understanding of the basis of the problem. It is also 
important to consider that the clinician having a relationship with the significant other may aid in 
identification of anxiety or depression in their partner (the mother) [deMontigny et al., 2013; 
Forsyth et al., 2011].  These factors may be important for future studies, but this study will focus 
on depressive symptoms of the mother. 
There are a multitude of factors that relate to a mother’s ability to cope with stress and 
depression.  Low educational level reduces the ability to cope with stress [Kubzansky et al., 
1999].  Poverty is also an underlying factor for pregnancy stressors as it seems to correlate with 
lack of access to quality health services, infant care and information [Lara et al., 2015]. In 
Mexico and other resource-restricted countries, there is a greater probability that perinatal 
depression will go undetected and untreated [Lara et. al., 2005].  This is probably due to total 
underutilization of mental health care services [Halbreich and Karkun, 2006; Borges et al, 2006; 
Matijasevich et al, 2009; Fisher et al., 2012].  Awareness of the social stigma correlated with 
depression in combination with reduced awareness in under-resourced areas may also prevent 
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women from seeking treatment [Lara et al., 2014].  One way to help close this prenatal 
healthcare gap is to increase awareness of pre and post natal depression.  Educating health care 
providers and expectant mothers and providing options to train health care providers to screen 
successfully for depression may help close this gap.  It is also important to assess more 
vulnerable mothers, such as those who are less educated, single, unemployed or impoverished to 
provide support networks [Lara et al, 2015]. 
Another important variable, relevant to our patient sample in Syracuse, is that residing in 
an urban environment is known to be more stressful than a rural community, perhaps due to the 
urban prevalence of noise, pollution, crime and overcrowding [Weinstock et al., 2001].  This 
conclusion has been drawn because schizophrenia and depressive symptoms in individuals have 
been more highly correlated with cities and areas with high population density [Marcelis et al., 
1998].  The concept of ‘urban stress’ simply exemplifies how even minor, seemingly 
insignificant stressors may actually have a significant impact on depression and pregnancy.  
Stressors may include everything from everyday life events, to daily hassles, to pre-existing 
medical conditions. Divorce, serious illness or death of a loved one, domestic affairs, financial 
problems, young age, poor preparation for pregnancy or delivery, low socioeconomic status, 
sexual abuse, unwanted pregnancy, lack of partner, psychiatric disorders and depressive 
symptoms are all classified as stressors that have the potential to affect pregnancy.  Major 
psychological and physiological disturbances associated with depression may have a significant 
impact on the pregnancy as well [Teixeira et al., 1999].  
The DSM-V defines perinatal or peripartum depression as major depression that occurs 
during pregnancy or in the period immediately subsequent to delivery [Lara et al., 2015]. 
Depression is typically characterized by reduced interest and pleasure in self, others and the 
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environment (anhedonia) and a decrease in general appetite and sexual activity [Weinstock et al., 
2001].   Clinicians often characterize the peripartum stage as ranging up to one year postpartum 
[O’Hara et al., 2013]. Identification of perinatal depression is imperative because it may have 
links to post partum depression (PPD), which may impair the affected women’s ability to care 
for herself and her baby [Lara et al., 2015].  Perinatal and post partum depression are associated 
with high usage of emergency rooms, malnutrition, developmental delay of the child and lower 
quality interactions between the mother and her child [Murray and Cooper, 1997; Field 2010]. 
 Perinatal depression has significant clinical value because it has detrimental effects on women’s 
health as well as pregnancy outcomes [Marcus et al., 2003].  Self reporting scales are useful as 
screening tools for further diagnostic assessment and for quick and accurate clinical 
measurements of depression [Lara et al., 2015].   
Between ten and twenty percent of women experience perinatal depression [Lee et al., 
2007].   Kwan et al. have found that the Edinburgh Postnatal Depression Scale (EPDS) can be 
used as a screening tool for depression and can additionally be used to measure dysphoria 
(Appendix B).  It can screen for a range of symptoms including depression, anxiety and 
anhedonic symptioms in many different settings. The Edinburgh scale can be administered by 
any level health care professional, trained in interviewing patients (Kwan et al., 2015).  Recent 
studies exploring high risk pregnancies showed that EPDS was able to successfully identify 
depression and anxiety [Thiagayson et al., 2012].  The present study will use the Edinburgh 
Postnatal Depression scale to analyze the incidence of depression in obese mothers during the 
perinatal period.        
Depression has found to be associated with premature births, miscarriages, longer 
hospital stays within the perinatal period, lower infant Apgar scores and smaller head 
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circumferences [Campagne, 2004; Orr et al., 2007; Lancaster et al., 2010; Chen et al., 2004; 
Stanton et al., 2002].  Pregnant women who are depressed are at an increased risk for delivering 
prematurely.  Premature infants are at a greater risk for low birth weights and having smaller size 
relative to their respective gestational age [Field et al., 2006].  The occurrence of preterm labor is 
also strongly associated with the stress-induced release of hypothalamic, pituitary and placental 
hormones [McClean et al, 1995; Wadhwa et al., 1998].  Therefore, early detection of possible 
depression is critical in preventing potential future complications in the mother and fetus.  
Clinician observation of the mother’s cognitive appraisal and coping strategies and access to 
resources is imperative for this reason [Arnal-Remon et al., 2014]. Because stress in pregnancy 
can influence the development of birth complications, it is important that early identification of 
mood disorders takes place to ensure successful, positive-outcome pregnancies [Arnal-Remon et 
al., 2014].  The American Psychological Association considers treatment for depression that is 
occurring during pregnancy to be a priority so that pospartum depression can be avoided 
[Spinelli et al., 2003; Heron et al., 2004]. 
 Neurotransmitters are essentially the modulators of depression. Suboptimal regulation of 
the HPA axis is generally linked to anxiety disorders and depression, where higher 
concentrations of cortisol can be found in both urinary and salivary samples [Arborelius et al., 
1999; Nemeroff et al., 1984]. Not surprisingly, depressed subjects show higher plasma and 
urinary levels of ACTH and catecholamines in response to a stressful situation [Gold et al., 1988; 
Holsboer et al., 1994, Heim et al., 2000].  Also, through blood sampling experimentation, beta-
endorphin concentrations (especially in chronic rather than episodic cases) have a positive 
correlation with stress and anxiety.  These hormones activate the HPA axis during pregnancy 
[Demyttenaiere et al., 1989; Wadhwa et al., 1996].    This physiological linkage between the 
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body’s stress systems and female reproductive tract has significant consequences for a 
pregnancy.       
Normal growth and development of a fetus can be significantly altered by a magnitude of 
factors including complications of pregnancy, maternal or fetal infections and teratogens.  
Teratogenic agents can disturb the normal development of the fetus [Mulder et al., 2002].  
Hormones and neurotransmitters released in excess by the body during depression or times of 
extreme stress are considered potential teratogens.     
Stressors activate the hypothalamus-pituitary-adrenal cortex system (HPA axis) and the 
sympathetic nervous system, or the adrenal medulla system.  Activation of these stress-systems 
releases excess corticotropin-releasing hormone (CRH), adrenocorticotropin-releasing hormone 
(ACTH), cortisol and (nor)adrenaline in the blood [Mulder et al., 2002].  These hormones 
deriving from the HPA axis in particular have a strong inhibiting effect on HPG and CRH.  
Cortisol receptors are numerous in the endometrium, ovaries and myometrium [Mulder et al., 
2002].  
Corticosteroids and catecholamines are known to strongly affect peripheral blood flow. 
Doppler blood flow studies using ultrasound to measure blood flow in vessels have shown that 
there is increased resistance of the uterine artery in women that experience high levels of anxiety 
thus altering the blood flow to the uterus [Teixeira et al., 1999].  Gestational stress can also cause 
an increase in CRH from the placenta, specifically catecholamines and cortisol and cause fetal 
hypoxia.  This is because hormonal shifts cause fluctuations in the mother’s blood vessel tone 
and heart contractions.  This demonstrates that gestational stress can affect fetal development 
[Petraglia et al, 1996; Sug-Tang et al., 1992]. 
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Maternal cortisol levels are linked to concentrations of fetal cortisol [Gitau et al., 1999]. 
Cortisol levels are transmitted through the placenta, thereby affecting the fetus [Chrousos et al., 
1998; Weinstock et al., 2011].  Activation of the fetal hypothalamus-pituitary-adrenal (HPA) 
axis in response to the mother’s psychological stress could have a significant impact on the 
offspring’s behavioral pathology later in life [Weinstock et al., 2011].  Specifically, maternal 
stress hormones may interfere with fetal levels of testosterone and aromatase at critical periods 
which may alter some masculine behaviors or morphologies later in life and cause cell loss in the 
fetal brain by disregulating the fetal HPA axis and altering normal development of the limbic 
system [Weinstock et al., 2011].  
It is generally assumed that maternal stress may impact the fetus through communication 
of stress hormones via the female reproductive system.  Possible transmission of maternal stress 
can include stress-induced release of CRH from the placenta to the intrauterine environment 
where the fetus is developing, transplacental transport of maternal hormones, and reduction of 
blood flow to the uterus and fetus [Mulder et al., 2002].   
The concept of ‘fetal programming’ relates to the concept that the fetal exposure to 
nutrients, proteins, hormones, temperature and infection will play a critical role in the 
development of the fetus.  Stress hormones have the capacity to participate in fetal programming 
(See Appendix C).   Programming in-vitro, is related to the incidence of cardiovascular and 
allergic diseases, hypertension, diabetes and schizophrenia [Mulder et al., 2002]. It is also 
important to note that when the mother experienced significant stress in early as opposed to mid-
gestation, the offspring had lower birth weights and more significant motor impairments 
[Schneider et al., 1999]. Damage inflicted on the developing fetus will depend on the timing of 
the given maternal (physiological or psychological) stressor relative to the development of the 
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fetus [Weinstock et al., 2011].  Studies have shown that gestational stress at 5 to 7 weeks 
gestation  may affect the development of the superoptic and paraventricular neucli and 
hypthalamus and regulation of HPA axis [Weinstock et al., 2011].   Therefore it is very 
important for clinicians and patients alike to be aware of physiological and psychological stress 
of pregnancy, due to the potential to induce a fetal complication.   
Proving that perinatal maternal stress and depression is linked to an offspring’s 
neurological and behavioral pathology is difficult because of the possibility that there is a genetic 
component in the mediation of these neuropathies and behavioral traits.  It is also important to 
note that the maternal stress may persist after birth and the infant’s development and behavior 
may be influenced by this latter behavioral influence of the mother [Weinstock et al, 2001].    It 
has been noted that, some individuals adopt passive behaviors when faced with unpleasant 
events.  This lack of control over aversive environmental events leads to the expectancy that 
future stimuli will be uncontrollable.  This in turn leads to a phenomenon known as ‘learned 
helplessness’.  Prenatal stress can, in some cases, exacerbate learned helplessness in the mother.  
Learned helplessness can clearly lead to poor child development and may strain early familial 
relationships between the mother and her child. [Seligmean, 1972; Secoli et al., 1998]      
However, regardless of the precise way in which maternal stress affects the newborn, it is 
important to minimize levels of stress.  Through genetics, placental development or parenting, 
the mother’s psyche will affect her newborn.  Additionally, the high risk associated with being 
obese while pregnant has the capacity to establish hazardous health conditions for the mother and 
her developing infant.  This area of medicine involving depression in obese maternal patients is 
critically important to understand.      
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Chapter 3 
Methods 
 
 
 
Design 
Taking advantage of the collaborative research ties between Syracuse University and 
Upstate Medical University, this project integrates research from principle investigator, Dr. 
Renee Mestad’s living study, “Correlates and Consequences of Prenatal Depression: An 
exploratory Study” with independently collected data for this study, “Maternal Obesity and 
Incidence of Depression”.  The current study has been exempt from IRB approval through 
association with Dr. Mestad’s study (IRB exemption #389664-1).  The current research team and 
Dr. Mestad’s research team both stand to benefit from the information collected, and society at 
large will benefit as well.  The research practice of collaborative efforts and data collection is 
perhaps one of the most efficient methods of research. It is cost effective and can lead to more 
accurate and clinically applicable research outcomes.  Combined, the breadth and depth of the 
information about prenatal and perinatal depression will provide compelling evidence for 
practioners to alter their patient treatment methods.  The statistical significance of our study is 
reinforced by the New York Statewide Perinatal Data System from 2013. This project will 
provide information that can have an immediate applied benefit in medicine.  It is an example of 
“incremental research”. A stepping stone that will advance researchers and medical practitioners 
alike with progression toward precise, personalized medicine.  The collaborative approach to 
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clarification and discovery of principles about human physiology and medical science is valuable 
in clinical medicine and therefore it is also pertinent and applicable to the field of Biotechnology. 
The following statements reflect the goals of Dr. Mestad’s research team’s studies and 
are from her Internal Review Board (IRB) exemption statement: 
“Dr. Mestad’s study aims to investigate the correlates and consequences of 
prenatal depression in the patient population served by Upstate University’s UHCC 
Women’s Health Clinic. Principal Investigators, Dr. Carrie Smith, Dr. Bruce Carter, and 
Dr. Sandra Lane, whom are all faculty professors within the David B. Falk College of 
Sport and Human Dynamics at Syracuse University, are recipients of the college’s SEED 
(Supporting Effective Educator Development) Grant amounting in $5000.00. These funds 
will act as the primary sponsor of this study. Dr. Renee Mestad, within the department of 
Obsterics and Gynecology at Upstate Medical University is also acting as a faculty 
Principal - 2 - Generated on IRBNet Investigator overseeing the chart review process at 
UHCC Clinic and Crouse Hospital… Per the 45 Code of Federal Regualtions, Part 46 
101.B, our intended study falls under the exemption category of research because it 
involves the collection and study of existing data, documents, and records. The study 
Principal Investigator, Renee Mestad, is an attending physician in the department of 
Obstetrics and Gynecology and has available access to patient antenatal and delivery 
charts at Upstate University Hospital and Crouse Hospital. The study design is a 
retrospective cohort design that will include the review of 350 antenatal and delivery 
charts within the following timeframe: 01/01/2010-12/31/2010… all data will be 
collected in a de-identified manner. 
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The collected data will not be linked directly nor indirectly to a specific patient 
record.  Upstate Medical University Women's Health Services conducts prenatal 
screening of all pregnant patients three times during the pregnancy. This proposed study 
will involve review of the prenatal and hospital delivery charts of 350 patients. The study 
is a retrospective cohort design that involves chart reviews of the antenatal and delivery 
charts of 350 pregnant Syracuse residents who delivered during the timeframe of 
01/01/2010-12/31/2010. All data abstracted will be collected in a de-identified manner 
within the chart review room at Upstate Medical University Hospital and Crouse 
Hospital. All chart reviews are listed on the de-identified form that is attached to this 
application. A quality control method that has been previously established in studies 
conducted by the CDC will be used during the chart review process. All chart reviewers 
are either staff or faculty of Upstate Medical University or students and volunteers 
associated with Syracuse University and have been granted the appropriate Upstate 
Medical access to review these charts.  
All chart reviewers are individuals familiar with Upstate University Hospital’s 
privacy policies as well as federal HIPPA guidelines. All have completed the appropriate 
CITI training as required by Upstate Medical University and Syracuse University. The 
variables that will be extracted for this study include the Edinburgh depression scores, 
maternal social and economic demographics, antecedent health and social conditions that 
might influence mood and emotional status, pregnancy related problems, and conditions 
that might affect stress and coping, and birth outcomes. The data abstraction form is 
attached to this application. This exemption application is also being simultaneously 
submitted to the Syracuse University and Crouse Hospital for IRB exemption.  
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Although the American College of Obstetricians and Gynecologists "strongly 
encourages" prenatal screening for depression, it is not routinely part of prenatal care in 
most clinical settings. UHCC/ WHS at Upstate Medical University is unusual in 
conducting this routine screening. UHCC/WHS also serves a very diverse group of low 
socioeconomic status patients. This chart review would allow us to collect quantitative 
data on a diverse group of pregnant women who were screened three times during the 
pregnancy as part of routine prenatal care. Prenatal screening of all pregnant patients 
occurs three times during the pregnancy with the Edinburgh assessment tool. Women 
who screen "positive" are interviewed by the on-site social worker to determine the extent 
and type of their emotional and psychological distress. The social worker then refers 
women who need additional therapeutic services. We are interested in answering the 
following questions:  
1.) What proportion of women screen positive for depression at once, twice, or three 
times during pregnancy?  
2.) What proportion of those who screen positive are referred for further care by the 
social worker?  
3.) What appeared to be the barriers to referral for additional care? Were any barriers 
associated with limitations of available services? Were any barriers due to refusal of 
Medicaid or other insurance denial of approval for the referral? Were any barriers due to 
the patient refusal to seek services?  
4.) What clinical and/or social conditions of the woman were associated with positive 
screens for depression?  
5.) What birth outcomes were associated with positive screens for depression?  
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6.) What proportion of women who were previously taking prescribed antidepressant 
medication prior to the pregnancy stopped the medication during the pregnancy? What 
proportion of women who stopped antidepressant medication during pregnancy screen 
positive for depression?  
The submitted data form will be used for data collection. A single master list 
(key) linking the subject's unique study number to medical record number will be secured 
in a locked location within Upstate, and always kept separate from the data forms. They 
will not contain any other information and will be destroyed immediately after medical 
record abstraction.” 
Dr. Mestad’s original research, combined with the present study’s data can be viewed in 
Appendix D.  The unique nature of the current study is that obesity will be studied in a graded 
manner.  BMIs of patients will be categorized in to ranges of >18.5 for underweight, 18.5-24.49 
for normal weight, 24.5-29.9 for overweight, 30-39.9 for obese and >40 for morbidly obese.  The 
incidence of depression among these groups of patients will be quantified and analyzed for 
statistically significant differences.  The current research team will then analyze how BMI 
correlates with the incidence of depression.  We hypothesize, based on the Central New York 
Database, that an increase in BMI will correlate with an increase in incidence of depression.   
To join the research objectives of the present group and Dr. Mestad’s research group, one 
of Dr. Mestad’s primary researchers, Meghan Hall, created an IRB addendum that added our 
research team’s objectives to Dr. Mestad’s current research initiative (see Appendix E).  Our 
research is not supported by the research grant that was awarded to Dr. Mestad’s team, although 
our research outcomes will benefit her team as well.  Karen Davis, secretary to Dr. Alex Spadola 
and administrative assistant for the Upstate Department of OB/GYN Center for Maternal and 
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Child Health lead the data collection for the current study in place of Dr. Keller who had to leave 
the study due to professional obligations.  Dr. Keller is a resident physician in the obstetrics and 
gynecology department at Upstate Medical University.  Ms. Davis will assist with the collection 
of retrospective data.  These patient data points are already included in the patient charts that 
have been examined by Dr. Mestad’s team.  The current research team will be able to determine 
the BMI of the patients previously examined by Dr. Mestad’s team.  Using the patient’s 
Edinburg Postnatal Depression Scale, Dr. Mestad’s team has depression scores for the patients 
that will be analyzed for this study.     
In this project, the Edinburgh Postnatal Depression Scale (EDPS) will be used to assess 
patients for depression in the antepartum stage of pregnancy, prior to delivery of the baby.  This 
scale has ten multiple choice questions that can be filled out by patients in approximately two 
minutes.  The result of the survey will be linked to the demographic and pre and post natal 
information for each patient to link the Edinburgh depression score with the physicality of 
patients.   The incidence of depression will indicate if there is a correlation between obesity and 
depression in pregnant women.  The clinical relevance of this information is that knowledge of 
an increased incidence of depression will help indicate populations where additional mental 
health preventive care is needed.  Ultimately, this will improve the effectiveness and 
personalization of medicine.  
The patients in this study have been asked by the nurse or physician responsible for the 
patient to respond to the questions on the Edinburgh scale.  The patient will be asked by their 
nurse or physician to be assessed during one of their routine pre-natal visits.  The patients will be 
told “Would you like to respond to a few questions regarding your mood during your 
pregnancy?” Using this information, health care providers will be better able to care for all of the 
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needs of women during pregnancy; not just the physical needs of pregnant patients, but the 
mental and psychological needs as well.  This study will also draw data from previously 
collected medical records to look at demographic information as well as the gestational age the 
baby was born, weight, APGAR score, # of days in the NICU if any, risk factors and BMI.  
These demographic analyses were primarily conducted by Dr. Mestad’s team.   There is no risk 
for the patient, except for the potential psychological cost associated with responding to a survey. 
 The basic methods and goals of the research is easily conveyed to the patients in a few 
sentences, which ensures that the patients have a complete understanding of the research they 
may choose to get involved with. 
 
Subject Characteristics 
The patient population served by Upstate University’s UHCC Women’s Health Clinic 
was used in this study.  These patients represent a populous from Syracuse, NY an urban 
community with a population of 145, 169 in 2010 (U.S. Census).  According to the 2010 US 
Census, Syracuse is 56.0% White, 29.5% Black, 8.3% Hispanic or Latino, 5.5% Asian, 5.1% 
Two or more races and 1.1 % American Indian or Alaska Natives.   
Specifically the current project will involve the review of prenatal and hospital delivery 
charts of 157 UHCC/WHS patients who were residents of Syracuse, New York and gave birth in 
2010.  
 
 
 
Instrumentation 
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 The Edinburgh Postnatal Depression Scale (EPDS) will be used (see Appendix B).  The 
EPDS was developed for postnatal depression, but it has been validated in antenatal women as 
well (Gibson et al., 2009).  The EPDS items were adapted from from the Irritability, Depression 
and Anxiety scale and the Hospital Anxiety and Depression Scale (Cox et al. 1987).  It has been 
proposed that dysphoria, or a state of poor emotional well-being that encompasses depressive 
and anxiety symptoms, rather than just depression alone, has been identified in perinatal mothers 
using the Edinburgh depression scale (Green 1998).  For the ultimate purpose of this study, it 
would be quite helpful if the EPDS screens for additional psychological maladies because this 
study aims to identify which patients need extra psychological screening to allow for a more 
enjoyable pregnancy and motherhood. 
 The Edinburgh Postnatal Depression Scale is a 10 question administered questionnaire 
that rates symptoms from 0 to 3 (Kwan et al., 2014).  This rating scale is done using a 4-point 
Likert scale (Kwan et al., 2014). Total score ranges from 0 to 30 with higher scores correlating 
with greater severity of psychological distress. Several different cutoff scores for depression 
have been established in different studies.  Some studies have used the cutoff 12/13 out of 20, 
others have used 14/15 out of 20 and still others have used a score of 1 or more on item 10 as 
indicators for perinatal depression (Gibson et al., 2009, Swalm et al., 2010, Kwan et al., 2014).  
This study is using a Edinburgh score of 10 as a cutoff for possibility of depression.              
 
Experimental Testing and Procedure 
The data was collected for this project in a retrospective fashion.  This means that a 
physician or health care provider gathered the information in the past.  This research team was 
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authorized by the IRB to access the medical records and the data subsequently.  This subsequent, 
retrospective data collection is what took place in this study.   
A Collaborative Institutional Training Initiative (CITI) certified individual well trained in 
patient interviewing previously collected the BMI and Edinburgh data.  The mission of CITI is 
"To promote the public's trust in the research enterprise by providing high quality, peer 
reviewed, web based, research education materials to enhance the integrity and 
professionalism of investigators and staff conducting research" (CITI Program Mission 
Statement).  Essentially, CITI certified individuals have additional ethics, confidentiality and 
patient interaction training.     
The CITI certified health trained interviewer then retrospectively collected BMI, 
Edinburgh perinatal depression score along with other demographic data.  The data was collected 
from paper charts from the UHCC (University Health Care Clinic, associated with Upstate 
Medical University).  Karen Davis ultimately retrospectively accessed the data for this study.    
Statistical Analysis 
Our model of data analysis was adoped from Lara et al.’s study that found the prevalence 
and incidence of perinatal depression and depressive symptoms among Mexican women.  In our 
study, frequencies were calculated for categorical data and means and standard deviations for 
continuous variables were calculated.  Period prevalence was defined as the proportion of total 
cases of depression in the first, second and third trimester. In our data set, Edinburgh 1 correlates 
to the Edinburgh scale administered in the first trimester, Edinburgh 2 correlates to the 
Edinburgh scale administered in the second trimester and Edinburgh 3 correlates to the 
Edinburgh scale administered in the third trimester.  Final analysis compared incidence of  
depressive symptoms to patient body mass index.  Edinburgh response rates for the various BMI 
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categories previously listed were also calculated to identify if individuals within a certain BMI 
category responded more or less frequently to the Edinburgh scale.  Statistical analyses were 
conducted using Statistical Package for the Social Sciences (SPSS).    
Limitations 
  A limitation for this study is that all self report scales including the Edinburgh Postnatal 
Depression Scale, yield higher depression rates than those based on clinical interviews 
[Halbreich et al., 2006]. It is important to note that the scale is administered by a health care 
professional but the patient uses her own discretion to answer the Edinburgh questions.  The 
higher depression rates yielded may be due to the rigidity in evaluative methods of the scale.  
Patients can’t verbalize specifically how they feel, they instead have to pick a number on the 
scale that most closely reflects their feelings.  Only psychometric properties are evaluated.  This 
could lead to faulty, inaccurate results because patient’s psychological anomalies that are not 
detectable will not be found.     
Women are typically given the diagnosis of depression and anxiety if they fulfill a set of 
criteria (Kwan et al., 2015).  Specifically tailored diagnosis cannot be discerned from the EPDS, 
patients can only be assigned to a generalized diagnostic category.   
Additionally, we do not have information regarding why certain women refused to be 
tested.  We also do not have the demographics of the women that refused to complete the survey.  
Although this is not a common limitation, knowing the psychological proclivities of the women 
who did not respond to the survey would help establish a more accurate data set and conclusion.  
Behaviors such as avoidance, antisocial interactions, lack of openness have been indicators of 
depression.  These behaviors, if they are partially exhibited by patients who refused to answer 
the survey, could indicate that some of the women who refused to answer the survey may in fact 
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have had some degree of depression.  The fact that this suject subset is not incorporated in the 
study may actually understate the results and the conclusions about obesity and perinatal 
depression.  It could also lead to us overstating our results and conclusions if these women were 
in fact not experiencing depression.      
We also have only tested women in the clinic.  This data reflects an urban population and 
does not include an accurate representation of suburban or rural communities.   
Delimitations 
The estimates based on the self-reported questionnaires are extremely cost efficient and 
do not required specially trained clinicians to administer the assessment [Robertson et al., 2003]. 
 Self reports still have very clinically significant information regarding their depression screening 
ability and it is important to utilize this technique because especially during the perinatal period, 
depressive symptoms may be very debilitating for the mother and may result in less desirable 
pregnancy outcomes [Marcus et al, 2003]. 
 The EPDS provides quick and simple information about mothers’ psychological state that 
does not need to be collected by a physician.  This makes it possible for more patients to be 
screened for depression, in situations where they may not have been screened at all due to the 
lack of accessibility or availability of a psychological health professional.  Using a simple survey 
screening tool like the EPDS is the first step in completely eliminating perinatal depression and 
preventing postpartum depression in the obese population.  
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Chapter 4 
Results 
 This study analyzed 157 patients.  These 157 deidentified patients were drawn from the 
S.E.E.D. dataset that contained 259 individuals.  The 157 individuals that were analyzed had a 
complete data set, including BMI and Edinburgh results.  For the 157 patients, the mean BMI 
was 30.8685.  The median BMI was 29.9500.  The BMI standard deviation was 7.30493.  The 
25th percentile for BMI in the patient population was 25.5750, the 50th percentile was 29.9500, 
the 75th percentile was 35.1000.  The range of BMIs in the study was 16.97(extremely 
underweight)  to 54.86 (extremely morbidly obese).  This is fairly surprising since the 50th 
percentile is on the verge of developing obesity. The frequency of each BMI is also listed on 
pages 1-5 of Appendix F.   
 Underweight mothers (BMI >18.5) composed 0.6% of the subject population, normal 
weight mothers (BMI 18.5-24.49) composed 19.1% of the subject population, overweight 
mothers (BMI 24.5-29.99) composed 30.6% of the population, obese mothers (BMI 30-39.99) 
consisted of the largest amount of the subject population, representing 38.3% of mothers and 
morbidly obese mothers (BMI ≥40) composed 11.5% of the subject population.   
 75.2% of all mothers scored less than 10 on the Edinburgh during all three trimesters, 
indicating that 75.2% of the population was not depressed.  24.2% of all mothers scored 10 or 
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greater on the Edinburgh scale at least once during all three trimesters, indicating that 24.2% of 
the subject population was depressed at some point during the study.  This study had a 99.4% 
response rate, meaning that 99.4% of the mothers given the survey responded from the subject 
population.   
 The median score for Edinburgh 1, administered during the first trimester, is 13.00 out of 
30, which is a score that indicates depression.  The median score for Edinburgh 2, administered 
during the second trimester, is 12.50 out of 30, which indicates presence of depression.  For 
Edinburgh 3, the vast majority of mothers did not have the Edinburgh administered, so no 
average score could be calculated for this trimester. (Please see Appendix F, page 8 and the 
Table titled “Frequencies” for this information.)   Appendix F, pages 6-8, show the frequency of 
the various scores on the Edinburgh scale for each trimester.  Interestingly, the highest 
Edinburgh score recorded in this study, which was recorded in Edinburgh 2 in the second 
trimester is a score of 26/30 (extremely depressed), which was reported for the subject who had 
the highest BMI in the study, 54.86 (morbidly obese) (Appendix F, page 9).  
 The most important data in this study is the crosstabulation of the BMI categories with 
incidence of depression.  0% of the underweight patients (BMI >18.5) were depressed. 
(However, there was only one underweight individual in this study.)  30.0% of the normal weight 
patients (BMI 18.5-24.99) were depressed.  29.2% of the overweight patients (BMI 25.00-29.99) 
were depressed.  13.6% of the obese patients (BMI 30-39.99) were depressed.  38.9% of the 
morbidly obese patients (BMI ≥40) were depressed.  This data can be seen in the crosstabulation 
table on page 16 of Appendix F.   
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 The mean BMI for not depressed individuals is 30.6614 and the mean BMI for possibly 
depressed individuals is 31.2989, seen on page 17 of Appendix F.  This difference is not 
statistically significant. 
 The response rate was also calculated for the separate BMI categories.  For Edinburgh 1, 
0.0% of underweight individuals did not respond, 30.0% of normal weight individuals did not 
respond, 43.8% of overweight individuals did not respond, 26.7% of obese individuals did not 
respond and 11.1% of morbidly obese individuals did not respond.  Fore Edinburgh 2, 0.0% of 
underweight individuals did not respond, 60.0% of normal weight individuals did not respond, 
43.8% of overwight individuals did not respond, 40.0% of obese individuals did not respond and 
11.1% of morbidly obese individuals did not respond.  This shows that underweight and 
morbidly obese individuals tended to respond to the Edinburgh scale more frequently than the 
other weight classes.  However, the underweight population only composed 0.6% of the subject 
population and the morbidly obese population only composed 11.5% of the subject population.  
Response rates for Edinburgh 3 were not calculated because the response rate was exceptionally 
low for the in this trimester.   
 Lastly, we ran a morbid obesity and possibility of depression crosstabulation.  Individuals 
who were not morbidly obese had a 22.5% incidence of depression.  Individuals who were 
morbidly obese had a 38.9% incidence of depression.        
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Chapter 5 
Discussion 
 
 
 
Our study has indicated that a BMI of ≥40 during the perinatal stage of pregnancy is 
correlated with a higher incidence of depression.  Our study also indicates that a BMI of <40 
during the perinatal stages of pregancy correlates to a moderate risk of depression in women.  
According to our data, women who are normal weight, overweight and mildly to moderately 
obese have a similar risk of developing depression during the perinatal stages of pregnancy.  On 
average, about 22.5% of underweight, normal weight, overweight and mildly to moderately 
obese women had depression, whereas 38.9% of morbidly obese women developed depression.        
This is partially consistent with previous studies which have found that depression and 
anxiety are co morbidities of obesity (Novick et al., 2005; Simon et al., 2006; Kloiber et al., 
2007; Singh, 2014  The significance of the present study is that the health of two individuals is 
found to be affected by perinatal obesity and depression: the mother and child.  Epigeneitics has 
shown us that risk factors such as maternal nutrition and stresses alter the risk of similar (obesity-
related) pathologies in her offspring from in-utero exposure (Singh, 2014).  Maternal obesity is 
associated with a increased risk of congenital defects (Arabin et al., 2014).  In cases of perinatal 
depression, not only can developing infants’ health be affected by the mother’s abnormal 
neurotransmitter and hormone levels in utero, the mother-child bond postpartum may be at risk 
as well.  A poor post-partum relationship between the child and mother can create an 
environment for the child that can accentuate any (epi)genetic predispositions to depression or 
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obesity (Singh, 2014).  Prior to this study, research projects on clinical correlations as they relate 
to treatment options have been lacking.  These types of studies are urgently needed in the field of 
high risk pregnancies  in obstetrics and gynecology to reduce the metabolic, cardiovascular and 
psychological risks for women and children and to minimize the consequential costs for society 
(Arabin et al., 2014).  The outcome of this study has relevance to not only to obstetrics and 
gynecology but also to pediatrics and child and family welfare.  On an individual basis, 
physiological and psychological wellness often precedes social productivity.  Since obesity is an 
increasing healthcare, social and even political issue in the United States, the issues of perinatal 
maternal obesity and depression are of critical imporatance.               
There has been sufficient physiological data collected that supports this study’s finding 
that exceptionally high BMI (morbid obesity; BMI ≥40) in the perinatal stage is correlated with 
depression.  Excess food and energy supply to the brain will result in abnormal brain physiology.  
According to Singh, foods have a direct influence on the brain and neurotransmitter systems 
(Singh 2014).  Excess food consumption can cause a shift in neurochemistry, which has a direct 
effect on brain structure, chemistry and physiology.  Mood can influence food choices and food 
choices can effect mood (Singh 2014). The physiological connection between depression and 
food consumption can lead to raised plasma levels of CRH, ACTH and cortisol in the mother 
which may lead to increased likelihood of preterm birth, developmental delays and behavioral 
abnormalities in children (Weinstock, 2001).    
Maternal obesity can cause methylation of cytidine based in cytosine-guanosine 
nucleotide dimmers (CpG) (DNA methylation).  This may lead to an epigenetic change that can 
be passed transgenerationally (Bird, 2002).  It has been found that total methylation in the 
placentas of obese women is significantly higher than in normal-weight women (Nomura et al., 
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2014).  This placental methylation can change the regulation of metabolism in the offspring and 
can also trigger development of chronic metabolic disorders and other physiological disorders 
potentially involving the brain (Nomura et al., 2014).    
There have been several trials, both randomized and non-randomized, that support 
providing women with evidence-based recommendations (Rasmussen et al., 2004; Dyson et al., 
2005).  There are a number of treatment protocols that health care providers should consider for 
women with a BMI of ≥30 (See Appendix G).  Maternity services need to identify what 
resources and services are locally available and accessible for specific patients.  According to 
Arabin (2014), the specific assistance that women with abnormal BMI should receive involves 
counseling with regards to diet, supplements, exercise and weight gain throughout the 
pregnancy.  Arabin et al., state that women should be counseled to be moderately active (for 30-
60 minutes per day) so that any dietary alteration made can be paralleled with activity so that fat-
free tissue is not lost (Arabin et al., 2015).  Health practitioners should also help women set 
weight gain goals based on their current BMI (see Appendix H) (Davies et al., 2003).  Women 
with a BMI of >27 have lower serum folate levels even after controlling for folate intake, which 
suggests that overweight and obese women should possibly receive higher supplemental doses of 
folate supplementation in order to minimize the risk of fetal neural tube defects (Arabin 2014).   
One issue that health care providers may discover in their counseling of patients is a lack 
of patient compliance or motivation.  Patients may be motivated by discussing with them that 
following dietary and exercise guidelines could reduce their risk for caesarean section, 
hypertension, abnormal birth weight in their children and birth defects in their children (Davies 
et al., 2003).  Another challenge ties in the fact that that low income and insufficient education 
are often associated with maternal obesity (Sutherland et al., 2013).  This makes clinical 
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interventions more complex.  Health care providers should take care to avoid stigmatizing 
patients, while identifying and communicating with patients about the consequences of further 
weight gain (Arabin et al., 2014).   
The period of time surrounding and encompassing pregnancy, including the perinatal 
stage of pregnancy, presents many opportunities for healthcare providers to maximize the health 
of the mother and child.  Maternal obesity is associated with the highest risk of miscarriages and 
stillbirths and even in the absence of these obstetric catastrophes, the mother and child continue 
to be at risk for multiple physiological complications (Arabin et al., 2014).  A concerted effort 
between politicians, media, general practitioners, midwives and obstetricians should be made to 
improve the health care outcome for women who experience perinatal obesity and depression.  A 
practice called strategic litigation by government and private attorneys is beginning to play a role 
in the obesity prevention movement by monitoring food marketing tactics (Graff et al., 2012).  
Strategic litigation can bring about significant public policy changes by taking carefully selected 
cases to court.  This type of political and legal involvement serves to draw public attention to the 
problem of obesity and food marketing; it fuels policy development and spurs industry to change 
its practices voluntarily (Graff et al., 2012).  Health care professionals should also consider 
engaging in the initiatives previously stated regarding preventive medicine practices as these 
tactics are essential in the fight against maternal obesity and depression.   
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Chapter 6 
Conclusion 
 
 
 
 
 
The purpose of the current study is to use biotechnological and clinical measurements to 
develop a greater understanding of how weight, body mass index (BMI) and obesity can 
influence perinatal depression.  This heightened understanding of perinatal depression can be 
used as a tool that can tailor medical care more precisely to an individual patients’ physiology.  
We have found that women with a BMI over 40 (whom are classified as morbidly obese) have an 
increased incidence of depression in pregnancy.  Clinically, this information is useful because 
mothers with BMIs >40 can be identified as being at greater risk for mental dysphoria, 
specifically depression. Clinical knowledge of the increased risk of depression can allow for 
greater preventive action such as additional screening procedures, more health care provider 
inquiry about the mother’s mental health status and engagement in more preventive medicine 
practices.   
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Moving forward is it important to consider how the screening procedures for obese and 
other potentially depression-inclined individuals can be made even more precise and accurate.  
One idea for further research may involve using an expanded scale called the Sheehan-Roland-
Moris Disability Scale (see Appendix I).  This scale is designed for implementation of scientific 
modeling to improve treatment outcomes.  Instead of providing patients with four choices to 
choose from to describe their feelings about a particular question, the Sheehan-Roland-Moris 
Disability Scale has ten choices for patients to choose from to describe their feelings about a 
given question.  The ten-option questions will likely lead to greater accuracy in assessment of 
patient psychological state.   
In healthcare and in society, it is our responsibility to cost-effectively use all the tools at 
our disposal, especially those of biotechnologically-developed origin which have been developed 
from physiological and statistically derived data, to better the health and medical treatment of all 
individuals. 
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